1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
  4. > Biopharmaceutical

Biopharmaceutical Sector: Get Market Research and Figures

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
30 votes

Global Biopharmaceutical Industry

The global biopharmaceutical industry (a part of the biotechnology market) is currently worth over $145 billion, according to research conducted by BioPlan Associates. The industry should exceed $167 billion in 2015, says IMARC. 

Biopharmaceuticals are used in the prevention and treatment of disease, and there are over 300 approved biopharmaceuticals on the market, with many in clinical development yet to come. The market has benefited from the need for pharmaceutical manufacturers to boost output, but it has a high risk factor, with only three out of 10 drugs that pass to the clinical phase receiving market clearance.

Cost containment and biosimilar entry in developed markets continue to see slow growth, but the market should expand thanks to biopharmaceutical capacity to outperform traditional small molecule drugs. Over the coming five-year period, factors such as development of emerging markets and a rich late-stage pipeline are expected to fuel growth.

Key Biopharmaceutical Market Segments

The world biosimilar market is expected to record yearly growth in excess of 50% between 2010 and 2015, reports RNCOS. Market growth is being driven by factors such as costly drugs, high pharmaceutical expenditure and a global aging population. Market expansion will be further fuelled by expiring patents and the increasing cost of drugs. Sandoz is the leading company operating in the global biosimilars market, recording the highest sales. Teva and Hospira are developing a biosimilar product range.

The global enzyme market is expected to exceed $7.5 billion in 2015, reports Freedonia, and it should surpass yearly growth of 5%. The fastest rate of growth will be recorded in smaller markets such as the Africa/Middle East region, and Central and South America. Asia-Pacific is expected to record strong growth, while the EU and North America are forecast to record below-average growth.

The global protein therapeutics market is forecast to see yearly growth of 13% between 2012 and 2014, reports RNCOS. Increased investment and the introduction of new protein therapeutics will fuel market  expansion. Protein therapeutics have been recording a high rate of growth in recent years, vital to the treatment of many diseases. Protein therapeutics are particularly efficient due to their targeted approach, which allows the treatment of disease with little or no negative impact on healthy organs. Protein therapies are necessary in a healthcare landscape, witnessing rapidly rising rates of chronic illnesses like cardiovascular diseases, diabetes and cancer.

The cancer monoclonal antibodies market is expected to grow at a yearly rate in excess of 5% between 2012 and 2015, according to RNCOS. Cancer monoclonal antibodies are used to treat tumors with a high degree of specification. The market is driven by increasing prevalence of cancer and the need for more innovation research. The industry is witnessing rising consolidation.

Read more »

Customer Support

Talk to Sam

+44 208 068 8943

290 Reports
Supply, Company, Demand
77 Statistics
Market Size, Finance, Company Financials
1300 Reports
Supply, Product Initiative, Company Financials
150 Statistics
Finance, Market Size, Company Financials
33 Reports
Demand, Company Financials, Market Size
21 Statistics
Demand, Market Size, Finance
150 Reports
Supply, Company Financials, Market Size
29 Statistics
Finance, Company Financials, Market Size
30 Reports
Supply, Company, M&A
11 Statistics
Market Size, Supply, Company
53 Reports
Company Financials, Company, Market Size
2 Statistics
Finance, Company Financials, Market Size
31 Reports
Company Financials, Supply, Product Initiative
3 Statistics
Market Size, Company, Supply
17 Reports
Supply, Company, Company Financials
3 Statistics
Market Size, Demand, Finance
48 Reports
Supply, Company Financials, Demand
5 Statistics
Finance, Company Financials, Market Size
11 Reports
Supply, Market Description, Market Size
1 Statistics
Market Size, Demand, Supply
Search in Biopharmaceutical Industry (About 2100 reports)
Parent industry: Medical Biotechnology

About 2500 reports

Purchase Reports From Reputable Market Research Publishers

2018 Global Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • € 18505
  • Industry report
  • June 2018

The new report is a seven-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the U.S., five ...

2018 Competing in the Global Hematology and Flow Cytome ... € 18505 April 2018

Market Spotlight: Hidradenitis Suppurativa € 14471 March 2018

2018 Global Hematology and Flow Cytometry Market: US, E ... € 13944 June 2018

2018 Global Hematology and Flow Cytometry Market Shares ... € 12717 September 2018

2018 Europe Hematology and Flow Cytometry Market: Analy ... € 11226 June 2018

2018 Europe Cancer Diagnostics Market: France, Germany, ... € 11226 June 2018

2018 Global Flow Cytometry Market: US, Europe, Japan--A ... € 10524 June 2018

Glioblastoma Multiforme (GBM): Opportunity Analysis and ... € 9643 October 2018

Peanut Allergy: Opportunity Analysis and Forecasts to 2 ... € 9643 June 2018

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on